Position in LLY
as of Mar 31, 2026
· filed May 1, 2026
Position Value
$603,907,185
-$191,177,692 QoQ
Shares Held
656,585
-11.3% QoQ
Ownership
0.070%
of shares outstanding
% of Portfolio
1.29%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 92.37052323766154.ToString("F0")%
Shared 0.ToString("F0")%
None 7.629476762338464.ToString("F0")%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026ROYAL LONDON ASSET MANAGEMENT LTD holds $3,896,027,978 across 10 Drug Manufacturers - General names. LLY ranks #2 (15.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
10,299,563 | $2,031,279,814 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
656,585 | $603,907,185 | |
| 3 | MRK |
Merck & Co., Inc.
|
2,896,154 | $348,378,364 | |
| 4 | JNJ |
Johnson & Johnson
|
1,202,690 | $293,985,543 | |
| 5 | ABBV |
AbbVie Inc.
|
1,351,717 | $293,984,930 | |
| 6 | AMGN |
Amgen Inc
|
281,362 | $98,997,219 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
571,333 | $79,626,680 | |
| 8 | PFE |
Pfizer Inc
|
2,823,465 | $79,282,897 |
All Filings in LLY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $603,907,185 | 656,585 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $795,084,877 | 739,834 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $568,702,813 | 745,351 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $550,147,840 | 705,743 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $642,635,615 | 778,094 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $572,278,968 | 741,294 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $639,975,591 | 722,369 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $711,040,183 | 785,350 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $660,990,602 | 849,646 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $518,915,966 | 890,201 | Shares | Sole | 2024-03-01 | |
| 2023-09-30 | $486,334,690 | 905,432 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $594,025,075 | 1,266,632 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $396,867,141 | 1,155,632 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $397,675,762 | 1,087,021 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $296,826,892 | 917,974 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $304,415,980 | 938,889 | Shares | Sole | 2022-09-06 | |
| 2022-03-31 | $239,535,904 | 836,456 | Shares | Sole | 2022-09-06 | |
| 2021-12-31 | $225,929,729 | 817,934 | Shares | Sole | 2022-10-18 | |
| 2021-09-30 | $186,727,447 | 808,169 | Shares | Sole | 2022-10-18 | |
| 2021-06-30 | $207,637,792 | 904,661 | Shares | Sole | 2022-10-18 | |
| 2021-03-31 | $163,823,392 | 876,905 | Shares | Sole | 2022-10-17 | |
| 2020-12-31 | $143,416,410 | 849,422 | Shares | Sole | 2021-01-29 | |
| 2020-09-30 | $122,433,558 | 827,142 | Shares | Sole | 2020-11-04 | |
| 2020-06-30 | $112,100,954 | 682,793 | Shares | Sole | 2020-07-31 | |
| 2020-03-31 | $96,737,363 | 697,357 | Shares | Sole | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||